· Weekly signal · REGN
Regeneron Pharmaceuticals (REGN) jumps 16.3% as weekly rebound broadens
The biotechnology stock’s four-week gain nearly matches the one-week move, but trend and Market Dynamics readings remain mixed.
Regeneron Pharmaceuticals (REGN) closed the latest week at 762.63 USD, rising 16.3% over one week and extending its four-week advance to 16.6%. The chart shows a weekly price path over 52 weeks, so the move is best read as weekly context rather than live intraday action.
Confirmation is partial. Volume finished above its 13-week average and Relative Strength was positive at 1.7, but the trend signal stayed inactive and Market Dynamics at -0.23 showed lingering pressure.